|
|
||||||||
Vascular and Interventional Radiology |
1 From the Tumor Targeted Cryotherapy Center, PLA General Navy Hospital, Beijing, China (H.W., Y.D., Y.Z., H.F., Z.N.); and Department of Radiology, Wayne State University School of Medicine, Detroit, Mich (P.J.L.). Received May 12, 2003; revision requested July 21; final revision received May 7, 2004; accepted June 28. Address correspondence to P.J.L., Department of Radiology, Harper University Hospital, 3990 John R St, Detroit, MI 48201 (e-mail: littrupp@karmanos.org).
PURPOSE: To perform and report initial experience with percutaneous cryotherapy (PCT) of the thorax.
MATERIALS AND METHODS: A human investigation committee approved the study protocol, and all patients gave informed consent. One hundred eighty-seven patients who were not surgical candidates underwent computed tomography (CT)-guided PCT for treatment of thoracic cancer masses. CT-visualized low-attenuating ice formation after PCT was compared with initial tumor size and location. At 1 week and at 1, 3, 6, and 12 months after PCT, the various findings seen on available CT scans and any complications were noted.
2 and Student t tests were used to identify significant differences in frequencies and mean values of imaging observations, respectively.
RESULTS: Ice formation was identified at CT as reduced attenuation values (in Hounsfield units) within soft-tissue masses, the mean sizes of which were 4.3 cm ± 0.2 (standard deviation) in peripheral locations and 6.4 cm ± 0.3 in central locations. Tumor size and location were independent predictors of tumor coverage by low-attenuating ice: Mean coverage was 99% for peripheral masses 4 cm or smaller (n = 101) and 80% for central masses larger than 4 cm (n = 58) (P < .001). An area of necrotic cavitation larger than the original mass developed in 80% (77 of 96) of masses within 1 week and was nearly resolved by 3 months in 7% (five of 76) of masses. By 6 months, minimal pulmonary scarring was noted in 56 patients and 86% of masses showed reduced or stable size. The overall rate of pneumothorax was only 12% (22 of 187 patients), and other side effects appeared to be self limited. No major bleeding or bronchial damage was noted. Two deaths in debilitated patients were temporally related, and two complications involved brachial and recurrent laryngeal nerve damage. The patient with laryngeal nerve damage regained speech within 2 months.
CONCLUSION: CT-guided PCT yielded low procedural morbidity given the extent of freezing, even near mediastinal structures. Ongoing advances in cryotechnology, imaging guidance, and treatment planning may help to avoid the degree of undertreatment of larger central masses observed in this study.
© RSNA, 2005
This article has been cited by other articles:
![]() |
M. R. Callstrom, T. D. Atwell, J. W. Charboneau, M. A. Farrell, M. P. Goetz, J. Rubin, J. A. Sloan, P. J. Novotny, T. J. Welch, T. P. Maus, et al. Painful Metastases Involving Bone: Percutaneous Image-guided Cryoablation--Prospective Trial Interim Analysis. Radiology, November 1, 2006; 241(2): 572 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ahmed and P. Littrup Percutaneous cryotherapy of the thorax: safety considerations for complex cases. Am. J. Roentgenol., June 1, 2006; 186(6): 1703 - 1706. [Full Text] [PDF] |
||||
![]() |
M. Kawamura, Y. Izumi, N. Tsukada, K. Asakura, H. Sugiura, H. Yashiro, K. Nakano, S. Nakatsuka, S. Kuribayashi, and K. Kobayashi Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1007 - 1013. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |